Literature DB >> 8538995

Pattern electroretinogram in treated ocular hypertension: a cross-sectional study after timolol maleate therapy.

A Colotto1, T Salgarello, A Giudiceandrea, L A De Luca, A Coppè, L Buzzonetti, B Falsini.   

Abstract

To investigate pattern electroretinogram changes in treated ocular hypertension, we evaluated pattern electroretinogram recordings of 48 hypertensive eyes following an 8-month timolol maleate therapy. During treatment, 27 of 48 eyes had normalized intraocular pressures (15-18 mm Hg), while 21 retained elevated values (21-25 mm Hg). Twenty-eight eyes with untreated hypertension (22-25 mm Hg) lasting at least 8 months, as well as 32 untreated, normotensive eyes served as controls. When compared to untreated normotensive controls, timolol-treated eyes with either elevated or normalized intraocular pressures showed reductions in the mean electroretinographic amplitudes. However, these amplitude reductions were substantially greater in treated eyes with elevated pressures as compared to those with normalized ones. Untreated hypertensive controls showed pattern electroretinogram reductions, with respect to normal values, that were comparable to those of treated hypertensive eyes, but larger than those of treated normotensive ones. These results indicate that, in treated ocular hypertension, pattern electroretinogram losses tend to be associated with moderately increased intraocular pressures in the range of 21-25 mm Hg. Electroretinographic abnormalities may be, at least in part, prevented only by lowering intraocular pressure into a normal range.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538995     DOI: 10.1159/000267663

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  15 in total

1.  Normative data for a user-friendly paradigm for pattern electroretinogram recording.

Authors:  Vittorio Porciatti; Lori M Ventura
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

2.  Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma.

Authors:  Lori M Ventura; William J Feuer; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

3.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

4.  Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study.

Authors:  Vincenzo Parisi; Francesco Oddone; Gloria Roberti; Lucia Tanga; Carmela Carnevale; Lucia Ziccardi; Gianluca Manni
Journal:  Adv Ther       Date:  2019-02-21       Impact factor: 3.845

5.  Pattern electroretinogram abnormality and glaucoma.

Authors:  Lori M Ventura; Vittorio Porciatti; Kyoko Ishida; William J Feuer; Richard K Parrish
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

6.  Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study.

Authors:  Lori M Ventura; Vittorio Porciatti
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

7.  Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram.

Authors:  Benedetto Falsini; Dario Marangoni; Tommaso Salgarello; Giovanna Stifano; Lucrezia Montrone; Salvatore Di Landro; Laura Guccione; Emilio Balestrazzi; Alberto Colotto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-17       Impact factor: 3.117

8.  Adaptation of the steady-state PERG in early glaucoma.

Authors:  Vittorio Porciatti; Brandon Bosse; Prashant K Parekh; Olga A Shif; William J Feuer; Lori M Ventura
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

9.  A new mouse model of inducible, chronic retinal ganglion cell dysfunction not associated with cell death.

Authors:  Xu Yang; Tsung-Han Chou; Marco Ruggeri; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

10.  Retrograde signaling in the optic nerve is necessary for electrical responsiveness of retinal ganglion cells.

Authors:  Tsung-Han Chou; Kevin K Park; Xueting Luo; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.